The US Government stopped an AIDS drug trial this week that was to determine if patients could take breaks from treatment. The trial showed immediate results, bad ones. People were much more likely to become ill or die if they took breaks.
Though small studies showed some benefits, larger international studies showed patients had twice the risk of dying or developing clinical AIDS if they took breaks. The breaks were hoped to lower resistance to drug cocktails which build up over time.
"Furthermore, there was an increase in major complications such as cardiovascular, kidney and liver diseases," said the National Institute of Allergy and Infectious Diseases. The trial had been in place in 33 countries and involved more than 5,000 patients.